期刊文献+

盐酸法舒地尔对脑梗死患者血清中CRP的影响 被引量:1

The effect of hydrochloride fasudil on the CRP in ACI patients
暂未订购
导出
摘要 目的观察盐酸法舒地尔对脑梗死患者血清C反应蛋白的影响。方法将我院神经内科2010年3月~2011年3月收治的126例急性脑梗死患者随机分为对照组和实验组各63例;对照组给予常规治疗,实验组在对照组治疗的基础上加用盐酸法舒地尔,观察治疗前后两组患者的血清CRP水平的变化及评估两组患者神经缺损积分和疗效。结果两组相比CRP水平明显降低(P<0.05),实验组神经功能缺损积分优于对照组(P<0.05),总有效率明显高于对照组(P<0.01)。结论盐酸法舒地尔可有效降低急性脑梗死患者血清CRP水平,抑制炎症因子表达,并有抑制血管内膜、平滑肌细胞增生、对抗动脉硬化等作用,对急性脑梗死的治疗和预后具有重要意义。 Objective To observe the effect of the hydrochloride fasudil to the C reactiqe protein (CRP) in the patients suf- fering the cerebra infarction. Methods All of 126 acute cerebral infarction (ACI) patients were chosen from the neuro-inte- hal department of our hospital from March of 2010 to March of 2011 and divided inio two groups randomly. 63 were control group with the common treatment and the others were experimental group with the hydrochloride fasudil therapy after the common treatment. To observe the differences of the CRP between the before and the after in the two groups with the treat- ments, then evaluated the score of neuro-function impairment and the therapeutic effectiveness. Results Compared to the control group, the CRP level in the experimental group declined dramatically (P 〈 0.05), The score of neuro-function im- pairment was better than the control (P 〈 0.05). And the whole therapeutic effectiveness was higher than the control (P 〈 0.01 ). Conclusion Hydrochloride fasudil could reduce the CRP level in ACI patients and depress the expression of the in- flammatory factor (IF). It also could depress the hyperplasia of the endangium and the smooth muscle cell and counteract the arteriosclerosis. It played a significant role in the ACI therapy and post.
作者 刘利红
出处 《中国现代医生》 2012年第10期70-71,共2页 China Modern Doctor
关键词 急性脑梗死:盐酸法舒地尔:C反应蛋白 Acute cerebral infarction Hydrochloric acid fasudil C-reactive protein
  • 相关文献

参考文献4

二级参考文献36

  • 1张明,孙晓川.法舒地尔的药理作用及其临床应用的研究进展[J].山西医科大学学报,2007,38(4):369-373. 被引量:71
  • 2Szalai AJ. The biological functions of C-reactive protein [J]. Vasc Pharmacol,2002,39:105-107.
  • 3Pepys MB, Hirschfield GM. C-reactive protein: a critical update [J].J Clin Invest,2003,111:1805-1812.
  • 4Torzewski M,Rist C,Mortensen RF, et al. C-reactive protein in the arterial intima[J]. Arterioscler Thromb Vac Biol, 2000,20:2094-2099.
  • 5Pasceri V,Willerson J,Yeh ET.Direct proinflammatory effect of c-reactive protein on human endothelial cells[J]. Circulation, 2002,102:2165-2168.
  • 6Verma S,Li SH,Badiwala MV, et al Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein[J].Circulation, 2002, 105(16):1890-1896.
  • 7Venugopal SK,Devaraj S,Yuhanna I, et al.Demonstration that c-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells[J]. Circulation, 2002,106:1439-1441.
  • 8Woollard KJ,Phillips DC,Griffiths HR. Direct modulatory effect of c-reactive protein on primary human monocyte adhesion to human endothelial cells[J].Clin Exp Immunol, 2002,130:256-262.
  • 9Zwaka TP,Hombach V,Torzewski J, C-reactive protein mediated low density lipoprotein uptake by macrophages[J].Circulation, 2001,103:1194-1197.
  • 10Venugopal SK, Devaraj S, Jialal I. C-reactive protein decreases prostacyclin release from human aortic endothelial cells[J]. Circulation,2003,108(14):1676-1678.

共引文献15890

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部